However, si-HOTAIR treatment resulted in a >50% decrease in tumor volume after 30 days, whereas treatment with the AXL inhibitor resulted in a much more modest reduction of <20%, strongly implying that other AXL-independent pathways make important contributions. Here, AXL is linked to neoplasm.